PD-1/PD-L1, VEGFR Antibody
SSGJ-707 is a bispecific recombinant humanized IgG4 monoclonal antibody inhibitor that targets PD-1 and VEGF. It is applicable in cancer research, particularly for advanced non-small cell lung cancer (NSCLC) and recurrent endometrial cancer.
Product Specifications
Target
VEGFR, PD-1/PD-L1
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cancer Biology; Cardiovascular Research; Immunology & Inflammation, Cardiovascular Research, Cell Biology, Immunology & Inflammation, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog